ImmuMap in long-term collaboration with Materia Medica Holding

ImmuMap Services, a state-of-the-art flow cytometry services company, is proud to announce the initiation of a long-term collaboration with pharma company Materia Medica Holding per September 6th 2017 and currently until the end of 2020.

We are at present investigating several compounds supplied by Materia Medica Holding to reveal their mechanism-of-action upon stimulation of human leukocytes from our in-house cell library. Using our multicolor flow cytometry expertise we will deliver high-quality data from which a decision can be taken.

Materia Medica Holding, located in Moscow, Russia, supply a broad portfolio of new class of medicines (released-active products) to patients all over the World, and we look forward to a long and fruitful relationship with Materia Medica Holding.